StockData
Tango Therapeutics, Inc. logo

Tango Therapeutics, Inc. (TNGX) stock

TNGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/30128% above fair value
$21.89−0.22 (-1.00%)

Close on Nov 18, 2026Market cap $3.69BP/E –Yield –

Tango Therapeutics price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tango Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 7.6× a year earlier. Over the last 5 years it ranged from 0.7× to 11.5×, with a median of 2.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20264.2×−1.9
2025Dec 31, 20256.2×+4.7
2024Dec 31, 20241.4×−2.2
2023Dec 29, 20233.6×+1.3
2022Dec 30, 20222.3×−0.3
2021Dec 31, 20212.6×−0.8
2020Dec 31, 20203.4×–

More Tango Therapeutics figures

See a number that looks wrong?